Rising Incidence of Cancer and Genetic Disorders Accelerating the Growth of Global Regenerative Medicine Market
Global Regenerative Medicine Market Growth
The global regenerative medicine market is growing at a healthy rate and the trend is expected to continue during the forecast period. The increase in thermal burns, occupational burn accidents, and chronic wounds is accelerating the demand for these products and contributing to the growth of the global regenerative medicine market. The positive trend in the market and the growth is attributable to the high prevalence and incidence rates of diseases such as cancers and genetic disorders worldwide. The product approvals and launches over the past five years have been positively impacting with significant growth of the global regenerative medicine market.
Facts to Know!
- The global regenerative medicine market has witnessed a rapid increase in mergers and acquisitions, which were valued at USD 60 billion - USD 70 billion.
- Multinational players such as Novartis, F. Hoffmann-La Roche, Gilead Sciences, Bristol-Myers Squibb, Celgene, and Pfizer are targeting emerging market players that have a strong product pipeline with potential of becoming the prominent therapy.
- Based on the end-user segment, hospitals are significant revenue contributor and accounts for the largest market share.
- Hoffmann-La Roche has entered the regenerative medicine field by acquiring Spark Therapeutics, a developer of gene therapy treatments.
Get your sample today!
Key Offerings:
- Market Size & Forecast by Revenue | 2020−2026
- Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
- Segmentation – A detailed analysis by application, product type, end-users and geography
- Competitive Landscape – 7 Key Company Profiles and 32 Other Prominent Vendors
Global Regenerative Medicine Market – Geographical Analysis
North America, Europe, and APAC is witnessing considerable growth and development in the regenerative medicine field. North America is expected to grow at a significant rate during the forecast period due to the presence of the highest number of regenerative medicine companies in this region. In 2020, the US accounted for a 96.91% share in the regenerative medicine market in North America. Gene therapies such as Kymriah, Yescarta, MACI, Epicel, Provenge, Apligraf, and Dermagraft is contributing to the growth of the market in the region. The regenerative medicine market in North America is expected to grow at a CAGR of 38.54% during the forecast period.
What Strategies are Adopted by the Players in the Global Regenerative Medicine Market?
Many vendors in the global regenerative medicine market are focusing on product innovation and improving distribution efficiency through successful marketing strategies. Players are focusing on strategies such as R&D activities, collaborations, product launches, mergers and acquisitions, market expansion, and diversification of product portfolios to remain competitive and tap the vast growth potential in the market. The key vendors in the market include Amgen, Bristol-Myers Squibb, Dendreon, F. Hoffmann-La Roche, Gilead Sciences, Novartis, Osiris, Organogenesis, and Vericel. The global regenerative market is highly consolidated due to the presence of key players and other prominent players that account for significant shares. Many key players have developed innovative therapies in the field of regenerative medicine market.
Looking for more information? Click Here
About Arizton Advisory & Intelligence
Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess the market landscape and to finalize fool proof business strategies. We are committed to providing inclusive market research reports and consulting services to clients from diversified industries including– Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-235-2040/+1 302 469 0707